Patent · US Active

Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators

US11136409B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2017
Grant dateOct 5, 2021
Priority date
Expiry dateOct 11, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention is based, in part, on the identification of novel USP10 biomarkers and modulators, and methods of use thereof, for identifying, assessing, preventing, and treating AML.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.